Literature DB >> 22806209

Impact of positive intraabdominal lavage cytology on the long-term prognosis of colorectal cancer patients.

Rita Temesi1, László Sikorszki, János Bezsilla, Akos Botos, Judit Kovács, Tibor Tihanyi.   

Abstract

BACKGROUND: Our aim was to investigate the presence of free cancer cells found in lavage cytology specimens taken from the proximity of tumors during the course of curative open and laparoscopic colorectal resections and then examine and compare the long-term disease outcomes in cases of negative and positive cytology. Based on the results, we were hoping to identify the place of peritumoral lavage cytology among prognostic factors for disease recurrence.
METHODS: Between January 1, 2005 and December 31, 2007 intraoperative peritoneal lavage cytology was performed in 145 patients who underwent curative colorectal procedures. In all, 37 of the procedures were laparoscopic resections.
RESULTS: Malignant cells were detected in the intraoperative peritoneal lavage cytology samples from 25 patients. Median follow-up was 47 months (3-81 months). Among the 25 patients with positive cytology; locoregional recurrence or distant metastasis was found in 14 during this period (56 %), whereas among the 120 patients with negative cytology the incidence was 28 (23 %).
CONCLUSIONS: The impact of tumor stage, lymph node status, and peritoneal lavage cytology on recurrence rates is significant. Tumor, nodal, and lavage cytology status can be organized hierarchically in relation to time of recurrence. Cytology is most important, with positivity rendering long-term prognosis unfavorable. When comparing surgical techniques (open versus laparoscopic), we found no significant difference in recurrence rates. Our study has shown that conventional peritoneal lavage cytology is a prognostic factor in the case of patients undergoing curative colorectal operations.

Entities:  

Mesh:

Year:  2012        PMID: 22806209     DOI: 10.1007/s00268-012-1713-y

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  16 in total

1.  Incidence and prognostic value of positive peritoneal cytology in colorectal cancer.

Authors:  I Kanellos; H Demetriades; E Zintzaras; A Mandrali; I Mantzoros; D Betsis
Journal:  Dis Colon Rectum       Date:  2003-04       Impact factor: 4.585

2.  Quantitative light microscopy of atypical mesothelial cells and malignant cells in ascitic fluid.

Authors:  F J van de Molengraft; M A van 't Hof; C J Herman; P G Vooijs
Journal:  Anal Quant Cytol       Date:  1982-09

3.  Long-term prognostic value of positive peritoneal washing in colon cancer.

Authors:  P Wind; B Norklinger; V Roger; A Kahlil; E Guin; R Parc
Journal:  Scand J Gastroenterol       Date:  1999-06       Impact factor: 2.423

4.  Pathogenesis of recurrences on the suture line following surgical resection for carcinoma of the colon.

Authors:  G Gricouroff
Journal:  Cancer       Date:  1967-05       Impact factor: 6.860

5.  The carcinoembryonic antigen and its prognostic impact on immunocytologically detected intraperitoneal colorectal cancer cells.

Authors:  I Vogel; H Francksen; E Soeth; D Henne-Bruns; B Kremer; H Juhl
Journal:  Am J Surg       Date:  2001-02       Impact factor: 2.565

6.  Prognostic value of microscopic peritoneal dissemination: comparison between colon and gastric cancer.

Authors:  P Vogel; J Rüschoff; S Kümmel; H Zirngibl; F Hofstädter; W Hohenberger; K W Jauch
Journal:  Dis Colon Rectum       Date:  2000-01       Impact factor: 4.585

7.  Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker.

Authors:  A Schott; I Vogel; U Krueger; H Kalthoff; H W Schreiber; W Schmiegel; D Henne-Bruns; B Kremer; H Juhl
Journal:  Ann Surg       Date:  1998-03       Impact factor: 12.969

8.  Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction.

Authors:  M Gerhard; H Juhl; H Kalthoff; H W Schreiber; C Wagener; M Neumaier
Journal:  J Clin Oncol       Date:  1994-04       Impact factor: 44.544

9.  Monoclonal antibody and cytological detection of free malignant cells in the peritoneal cavity during resection of colorectal cancer--can monoclonal antibodies do better?

Authors:  N S Ambrose; F MacDonald; J Young; H Thompson; M R Keighley
Journal:  Eur J Surg Oncol       Date:  1989-04       Impact factor: 4.424

10.  Exfoliated cells and in vitro growth in colorectal cancer.

Authors:  D Skipper; A J Cooper; J E Marston; I Taylor
Journal:  Br J Surg       Date:  1987-11       Impact factor: 6.939

View more
  5 in total

Review 1.  Intra-operative peritoneal lavage for colorectal cancer.

Authors:  Guillaume Passot; Kayvan Mohkam; Eddy Cotte; Olivier Glehen
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

Review 2.  Incidence and prognostic significance of positive peritoneal lavage in colorectal cancer.

Authors:  Takeshi Nishikawa; Eiji Sunami; Toshiaki Tanaka; Junichiro Tanaka; Tomomitsu Kiyomatsu; Kazushige Kawai; Keisuke Hata; Shinsuke Kazama; Hiroaki Nozawa; Soichiro Ishihara; Toshiaki Watanabe
Journal:  Surg Today       Date:  2014-11-07       Impact factor: 2.549

3.  The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgery : proceedings of a consensus conference.

Authors:  K Søndenaa; P Quirke; W Hohenberger; K Sugihara; H Kobayashi; H Kessler; G Brown; V Tudyka; A D'Hoore; R H Kennedy; N P West; S H Kim; R Heald; K E Storli; A Nesbakken; B Moran
Journal:  Int J Colorectal Dis       Date:  2014-01-31       Impact factor: 2.571

Review 4.  Prognostic significance of isolated tumor cells in patients with colorectal cancer in recent 10-year studies.

Authors:  Yoshito Akagi; Tetsushi Kinugasa; Yosuke Adachi; Kazuo Shirouzu
Journal:  Mol Clin Oncol       Date:  2013-05-09

5.  Intraoperative peritoneal lavage: limitations of current evidence for clinical implementation.

Authors:  Duck-Woo Kim
Journal:  Ann Coloproctol       Date:  2014-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.